
doi: 10.1586/ehm.09.21
pmid: 21082968
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the different steps of their management. The reader is given an overview of the current PET-based interventional lymphoma trials and an insight into possible future developments in the field, including new PET tracers.
Lymphoma, Fluorodeoxyglucose F18, Lymphoma, Non-Hodgkin, Positron-Emission Tomography, Humans, Radiopharmaceuticals, Hodgkin Disease
Lymphoma, Fluorodeoxyglucose F18, Lymphoma, Non-Hodgkin, Positron-Emission Tomography, Humans, Radiopharmaceuticals, Hodgkin Disease
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
